Identification and validation of circulating miRNAs as endogenous controls in obstructive sleep apnea

dc.contributor.author
Santamaría Martos, Fernando
dc.contributor.author
Benítez, Iván
dc.contributor.author
Zapater, Andrea
dc.contributor.author
Girón, Cristina
dc.contributor.author
Pinilla, Lucía
dc.contributor.author
Fernández Real, José Manuel
dc.contributor.author
Barbé Illa, Ferran
dc.contributor.author
Ortega Delgado, Francisco José
dc.contributor.author
Sánchez de la Torre, Manuel
dc.date.accessioned
2024-12-05T22:31:32Z
dc.date.available
2024-12-05T22:31:32Z
dc.date.issued
2019-12-18T10:52:24Z
dc.date.issued
2019-12-18T10:52:24Z
dc.date.issued
2019-03-13
dc.identifier
https://doi.org/10.1371/journal.pone.0213622
dc.identifier
1932-6203
dc.identifier
http://hdl.handle.net/10459.1/67742
dc.identifier.uri
http://hdl.handle.net/10459.1/67742
dc.description.abstract
microRNAs (miRNAs) are non-coding RNAs highly relevant as biomarkers for disease. A seminal study that explored the role of miRNAs in obstructive sleep apnea syndrome (OSA) demonstrated their usefulness in clinical management. Nevertheless, the miRNAs that may act as endogenous controls (ECs) have not yet been established. The identification of ECs would contribute to the standardization of these biomarkers in OSA. The objective of the study is to identify miRNAs that can be used as ECs in OSA. We evaluated 100 patients divided into two different cohorts: a learning cohort of 10 non-OSA and 30 OSA patients, and a validation cohort (20 non-OSA and 40 OSA patients). In the learning cohort, a profile of 188 miRNAs was determined in plasma by TaqMan Low Density Array. The best EC candidates were identified by mean center+SD normalization and concordance correlation restricted normalization. The results were validated using NormFinder and geNorm to assess the stability of those ECs. Eight miRNAs were identified as EC candidates. The combination miRNA-106a/miRNA-186 was identified as the most stable among all candidates. We identified a set of ECs to be used in the determination of circulating miRNA in OSA that may contribute to the homogeneity of results.
dc.description.abstract
The project is supported by PI 14/01266 and PI 18/00449 from the Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER), Sociedad Española de Neumología y Cirugía Torácica (SEPAR) and Societat Catalana de Pneumologia (SOCAP). The work is supported by IRBLleida Biobank (B.0000682) and PLATAFORMA BIOBANCOS PT17/0015/0027”. We thank all the investigators of Sleep Unit of Santa Maria Hospital. F.S.-M. is the recipient of a predoctoral fellowship from “AGAUR-University of Lleida” and Convocatòria d’Ajuts 2018 de Promoció a la Recerca en Salut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
dc.language
eng
dc.publisher
Public Library of Science
dc.relation
Reproducció del document publicat a https://doi.org/10.1371/journal.pone.0213622
dc.relation
Plos One, 2019, vol. 14, núm. 3, p. e0213622
dc.rights
cc-by (c) Santamaria-Martos et al., 2019
dc.rights
info:eu-repo/semantics/openAccess
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.subject
Síndromes d'apnea del son
dc.subject
Marcadors bioquímics
dc.subject
MicroARN
dc.title
Identification and validation of circulating miRNAs as endogenous controls in obstructive sleep apnea
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)